Hepatitis C elimination among people who inject drugs: Challenges and recommendations for action within a health systems framework

The burden of hepatitis C infection is considerable among people who inject drugs (PWID), with an estimated prevalence of greater than 40%, representing an estimated 5.6 million people who have recently injected drugs living with hepatitis C infection. As such, PWID are a priority population for enh...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Liver Int
Autors principals: Day, Emma, Hellard, Margaret, Treloar, Carla, Bruneau, Julie, Martin, Natasha K, Øvrehus, Anne, Dalgard, Olav, Lloyd, Andrew, Dillon, John, Hickman, Matt, Byrne, Jude, Litwin, Alain, Maticic, Mojca, Bruggmann, Philip, Midgard, Havard, Norton, Brianna, Trooskin, Stacey, Lazarus, Jeffrey V, Grebely, Jason
Format: Artigo
Idioma:Inglês
Publicat: 2018
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6868526/
https://ncbi.nlm.nih.gov/pubmed/30157316
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/liv.13949
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars